Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial

Maria Ruiz-Vico,Daniel Wetterskog,Francesco Orlando, Suparna Thakali,Anna Wingate,Anuradha Jayaram,Paolo Cremaschi,Osvaldas Vainauskas,Nicole Brighi, Daniel Castellano-Gauna,Lennart Åström,Vsevolod B. Matveev,Sergio Bracarda,Adil Esen,Susan Feyerabend,Elżbieta Senkus, Marta López-Brea Piqueras,Santosh Gupta,Rick Wenstrup,Gunther Boysen

European Urology Oncology（2024）

引用 0|浏览9

关键词

Metastatic castration-resistant prostate cancer,Liquid biopsy resistance biomarker,Plasma circulating tumor DNA,Androgen receptor gain,Circulating tumor cells,Androgen receptor splice variants,PRESIDE trial,Enzalutamide,Docetaxel

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要